{
    "info": {
        "nct_id": "NCT06412497",
        "official_title": "MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.",
        "inclusion_criteria": "* Idiopathic Severe Aplastic Anemia (SAA), characterized by one of the following:\n\n  1. Refractory cytopenia(s), with 1+ of the following:\n\n     1. Platelets <20,000/uL or transfusion dependent\n     2. Absolute neutrophil count <500/uL without hematopoietic growth factor support\n     3. Absolute reticulocyte count <60,000/uL AND bone marrow cellularity <50% (with < 30% residual hematopoietic cells)\n  2. Early myelodysplastic features (bone marrow (BM) blasts <5%), without history of MDS/AML pre-treatment.\n  3. Idiopathic SAA with post-HCT graft failure (blood/marrow donor chimerism <5%) requiring a 2nd allogeneic HCT\n* Paroxysmal Nocturnal Hemoglobinuria (PNH), including AA-PNH overlap syndrome, acquired pure red cell aplasia (aPRCA), or acquired amegakaryocytic thrombocytopenia (aAT), characterized by one of the following:\n\n  1. Refractory cytopenia(s), with 1+ of the following:\n\n     1. Platelets <20,000/uL or transfusion dependent\n     2. Absolute neutrophil count <500/uL without hematopoietic growth factor support\n     3. Absolute reticulocyte count <60,000/uL or red cell transfusion dependent AND Bone marrow evidence of 1 to 3-lineage aplasia OR peripheral blood PNH clone >/= 10%\n  2. Early myelodysplastic features (bone marrow (BM) blasts <5%) without history of MDS/AML pre-treatment.\n  3. Idiopathic PNH, aPRCA, or aAT with post-HCT graft failure (blood/marrow donor chimerism <5%) requiring a 2nd allogeneic HCT\n* Adequate organ function within 30 days of conditioning regimen\nHealthy volunteers allowed\nMust have minimum age of 0 Years\nMust have maximum age of 75 Years",
        "exclusion_criteria": "* Pregnant, breastfeeding or intending to become pregnant during the study. Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment\n* Uncontrolled infection\n* Evidence of moderate or severe portal fibrosis or cirrhosis on biopsy\n* Known allergy to any of the study components\n* Prior radiation therapy deemed excessive by radiation therapist for proposed low dose TBI exposure on this protocol\n* Diagnosis of an inherited bone marrow failure disorder such as Fanconi anemia, Telomere biology disorder, or Schwachman-Diamond syndrome, unless reviewed by the principal investigator and deemed appropriate for this approach (e.g. GATA2 deficiency)\n* Advanced myelodysplastic syndrome (MDS; BM blasts >5%) or acute myeloid leukemia\n* Psychiatric illness/social situations that, in the judgement of the enrolling Investigator, would limit compliance with study requirements\n* Other illness or a medical issue that, in the judgement of the enrolling Investigator, would exclude the patient from participating in this study",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "1. Refractory cytopenia(s), with 1+ of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Refractory cytopenia(s)",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "refractory_status",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Refractory cytopenia(s)",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "refractory_status",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Idiopathic PNH, aPRCA, or aAT with post-HCT graft failure (blood/marrow donor chimerism <5%) requiring a 2nd allogeneic HCT",
                "criterions": [
                    {
                        "exact_snippets": "Idiopathic PNH",
                        "criterion": "idiopathic paroxysmal nocturnal hemoglobinuria (PNH)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "aPRCA",
                        "criterion": "acquired pure red cell aplasia (aPRCA)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "aAT",
                        "criterion": "acquired aplastic anemia (aAT)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "post-HCT graft failure (blood/marrow donor chimerism <5%)",
                        "criterion": "post-hematopoietic cell transplantation (HCT) graft failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "post-HCT graft failure (blood/marrow donor chimerism <5%)",
                        "criterion": "post-hematopoietic cell transplantation (HCT) graft failure",
                        "requirement": {
                            "requirement_type": "blood/marrow donor chimerism",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "requiring a 2nd allogeneic HCT",
                        "criterion": "need for second allogeneic hematopoietic cell transplantation (HCT)",
                        "requirement": {
                            "requirement_type": "necessity",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Idiopathic PNH",
                                "criterion": "idiopathic paroxysmal nocturnal hemoglobinuria (PNH)",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "aPRCA",
                                "criterion": "acquired pure red cell aplasia (aPRCA)",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "aAT",
                                "criterion": "acquired aplastic anemia (aAT)",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "post-HCT graft failure (blood/marrow donor chimerism <5%)",
                                "criterion": "post-hematopoietic cell transplantation (HCT) graft failure",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "post-HCT graft failure (blood/marrow donor chimerism <5%)",
                                "criterion": "post-hematopoietic cell transplantation (HCT) graft failure",
                                "requirement": {
                                    "requirement_type": "blood/marrow donor chimerism",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 5,
                                        "unit": "%"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "requiring a 2nd allogeneic HCT",
                                "criterion": "need for second allogeneic hematopoietic cell transplantation (HCT)",
                                "requirement": {
                                    "requirement_type": "necessity",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Idiopathic Severe Aplastic Anemia (SAA), characterized by one of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Idiopathic Severe Aplastic Anemia (SAA)",
                        "criterion": "Idiopathic Severe Aplastic Anemia (SAA)",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Idiopathic Severe Aplastic Anemia (SAA)",
                        "criterion": "Idiopathic Severe Aplastic Anemia (SAA)",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Absolute reticulocyte count <60,000/uL AND bone marrow cellularity <50% (with < 30% residual hematopoietic cells)",
                "criterions": [
                    {
                        "exact_snippets": "Absolute reticulocyte count <60,000/uL",
                        "criterion": "absolute reticulocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 60000,
                                "unit": "/uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "bone marrow cellularity <50%",
                        "criterion": "bone marrow cellularity",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "< 30% residual hematopoietic cells",
                        "criterion": "residual hematopoietic cells in bone marrow",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute reticulocyte count <60,000/uL",
                        "criterion": "absolute reticulocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 60000,
                                "unit": "/uL"
                            }
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "bone marrow cellularity <50%",
                                "criterion": "bone marrow cellularity",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 50,
                                        "unit": "%"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "< 30% residual hematopoietic cells",
                                "criterion": "residual hematopoietic cells in bone marrow",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 30,
                                        "unit": "%"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 0 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 0 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 0 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Absolute neutrophil count <500/uL without hematopoietic growth factor support",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count <500/uL",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 500,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without hematopoietic growth factor support",
                        "criterion": "hematopoietic growth factor support",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count <500/uL",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 500,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without hematopoietic growth factor support",
                        "criterion": "hematopoietic growth factor support",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Absolute reticulocyte count <60,000/uL or red cell transfusion dependent AND Bone marrow evidence of 1 to 3-lineage aplasia OR peripheral blood PNH clone >/= 10%",
                "criterions": [
                    {
                        "exact_snippets": "Absolute reticulocyte count <60,000/uL",
                        "criterion": "absolute reticulocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 60000,
                                "unit": "/uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "red cell transfusion dependent",
                        "criterion": "red cell transfusion dependence",
                        "requirement": {
                            "requirement_type": "dependence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Bone marrow evidence of 1 to 3-lineage aplasia",
                        "criterion": "bone marrow lineage aplasia",
                        "requirement": {
                            "requirement_type": "number of lineages with aplasia",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "lineage"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "lineage"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "peripheral blood PNH clone >/= 10%",
                        "criterion": "peripheral blood PNH clone",
                        "requirement": {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "or_criteria": [
                                    {
                                        "exact_snippets": "Absolute reticulocyte count <60,000/uL",
                                        "criterion": "absolute reticulocyte count",
                                        "requirement": {
                                            "requirement_type": "quantity",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 60000,
                                                "unit": "/uL"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "red cell transfusion dependent",
                                        "criterion": "red cell transfusion dependence",
                                        "requirement": {
                                            "requirement_type": "dependence",
                                            "expected_value": true
                                        }
                                    }
                                ]
                            },
                            {
                                "exact_snippets": "Bone marrow evidence of 1 to 3-lineage aplasia",
                                "criterion": "bone marrow lineage aplasia",
                                "requirement": {
                                    "requirement_type": "number of lineages with aplasia",
                                    "expected_value": {
                                        "comparisons": [
                                            {
                                                "operator": ">=",
                                                "value": 1,
                                                "unit": "lineage"
                                            },
                                            {
                                                "operator": "<=",
                                                "value": 3,
                                                "unit": "lineage"
                                            }
                                        ]
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "peripheral blood PNH clone >/= 10%",
                        "criterion": "peripheral blood PNH clone",
                        "requirement": {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Idiopathic SAA with post-HCT graft failure (blood/marrow donor chimerism <5%) requiring a 2nd allogeneic HCT",
                "criterions": [
                    {
                        "exact_snippets": "Idiopathic SAA",
                        "criterion": "idiopathic severe aplastic anemia (SAA)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "post-HCT graft failure",
                        "criterion": "graft failure after hematopoietic cell transplantation (HCT)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": "post-HCT graft failure"
                        }
                    },
                    {
                        "exact_snippets": "blood/marrow donor chimerism <5%",
                        "criterion": "blood/marrow donor chimerism",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "requiring a 2nd allogeneic HCT",
                        "criterion": "requirement for second allogeneic hematopoietic cell transplantation (HCT)",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Idiopathic SAA",
                        "criterion": "idiopathic severe aplastic anemia (SAA)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "post-HCT graft failure",
                        "criterion": "graft failure after hematopoietic cell transplantation (HCT)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": "post-HCT graft failure"
                        }
                    },
                    {
                        "exact_snippets": "blood/marrow donor chimerism <5%",
                        "criterion": "blood/marrow donor chimerism",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "requiring a 2nd allogeneic HCT",
                        "criterion": "requirement for second allogeneic hematopoietic cell transplantation (HCT)",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Platelets <20,000/uL or transfusion dependent",
                "criterions": [
                    {
                        "exact_snippets": "Platelets <20,000/uL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 20000,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependent",
                        "criterion": "transfusion dependence",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Platelets <20,000/uL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 20000,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependent",
                        "criterion": "transfusion dependence",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Refractory cytopenia(s), with 1+ of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Refractory cytopenia(s)",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "refractory_status",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Refractory cytopenia(s)",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "refractory_status",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Absolute neutrophil count <500/uL without hematopoietic growth factor support",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count <500/uL",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 500,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without hematopoietic growth factor support",
                        "criterion": "hematopoietic growth factor support",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count <500/uL",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 500,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without hematopoietic growth factor support",
                        "criterion": "hematopoietic growth factor support",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Paroxysmal Nocturnal Hemoglobinuria (PNH), including AA-PNH overlap syndrome, acquired pure red cell aplasia (aPRCA), or acquired amegakaryocytic thrombocytopenia (aAT), characterized by one of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
                        "criterion": "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "AA-PNH overlap syndrome",
                        "criterion": "AA-PNH overlap syndrome",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "acquired pure red cell aplasia (aPRCA)",
                        "criterion": "acquired pure red cell aplasia (aPRCA)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "acquired amegakaryocytic thrombocytopenia (aAT)",
                        "criterion": "acquired amegakaryocytic thrombocytopenia (aAT)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
                        "criterion": "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "AA-PNH overlap syndrome",
                        "criterion": "AA-PNH overlap syndrome",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "acquired pure red cell aplasia (aPRCA)",
                        "criterion": "acquired pure red cell aplasia (aPRCA)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "acquired amegakaryocytic thrombocytopenia (aAT)",
                        "criterion": "acquired amegakaryocytic thrombocytopenia (aAT)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have maximum age of 75 Years",
                "criterions": [
                    {
                        "exact_snippets": "maximum age of 75 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 75,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "maximum age of 75 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 75,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Early myelodysplastic features (bone marrow (BM) blasts <5%), without history of MDS/AML pre-treatment.",
                "criterions": [
                    {
                        "exact_snippets": "Early myelodysplastic features (bone marrow (BM) blasts <5%)",
                        "criterion": "bone marrow blasts",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Early myelodysplastic features (bone marrow (BM) blasts <5%)",
                        "criterion": "bone marrow blasts",
                        "requirement": {
                            "requirement_type": "myelodysplastic features",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without history of MDS/AML pre-treatment",
                        "criterion": "history of MDS/AML pre-treatment",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Early myelodysplastic features (bone marrow (BM) blasts <5%)",
                                "criterion": "bone marrow blasts",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 5,
                                        "unit": "%"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Early myelodysplastic features (bone marrow (BM) blasts <5%)",
                                "criterion": "bone marrow blasts",
                                "requirement": {
                                    "requirement_type": "myelodysplastic features",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "without history of MDS/AML pre-treatment",
                        "criterion": "history of MDS/AML pre-treatment",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Platelets <20,000/uL or transfusion dependent",
                "criterions": [
                    {
                        "exact_snippets": "Platelets <20,000/uL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 20000,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependent",
                        "criterion": "transfusion dependence",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Platelets <20,000/uL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 20000,
                                "unit": "uL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependent",
                        "criterion": "transfusion dependence",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Adequate organ function within 30 days of conditioning regimen",
                "criterions": [
                    {
                        "exact_snippets": "Adequate organ function within 30 days of conditioning regimen",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate organ function within 30 days of conditioning regimen",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate organ function within 30 days of conditioning regimen",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate organ function within 30 days of conditioning regimen",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Early myelodysplastic features (bone marrow (BM) blasts <5%) without history of MDS/AML pre-treatment.",
                "criterions": [
                    {
                        "exact_snippets": "Early myelodysplastic features",
                        "criterion": "myelodysplastic features",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Early myelodysplastic features",
                        "criterion": "myelodysplastic features",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "early"
                        }
                    },
                    {
                        "exact_snippets": "bone marrow (BM) blasts <5%",
                        "criterion": "bone marrow blasts",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without history of MDS/AML pre-treatment",
                        "criterion": "history of MDS/AML pre-treatment",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Early myelodysplastic features",
                        "criterion": "myelodysplastic features",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Early myelodysplastic features",
                        "criterion": "myelodysplastic features",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "early"
                        }
                    },
                    {
                        "exact_snippets": "bone marrow (BM) blasts <5%",
                        "criterion": "bone marrow blasts",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without history of MDS/AML pre-treatment",
                        "criterion": "history of MDS/AML pre-treatment",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "* Other illness or a medical issue that, in the judgement of the enrolling Investigator, would exclude the patient from participating in this study",
                "criterions": [
                    {
                        "exact_snippets": "Other illness or a medical issue that, in the judgement of the enrolling Investigator, would exclude the patient from participating in this study",
                        "criterion": "other illness or medical issue",
                        "requirement": {
                            "requirement_type": "investigator judgement of exclusion",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Other illness or a medical issue that, in the judgement of the enrolling Investigator, would exclude the patient from participating in this study",
                        "criterion": "other illness or medical issue",
                        "requirement": {
                            "requirement_type": "investigator judgement of exclusion",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Psychiatric illness/social situations that, in the judgement of the enrolling Investigator, would limit compliance with study requirements",
                "criterions": [
                    {
                        "exact_snippets": "Psychiatric illness ... would limit compliance with study requirements",
                        "criterion": "psychiatric illness",
                        "requirement": {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    },
                    {
                        "exact_snippets": "social situations ... would limit compliance with study requirements",
                        "criterion": "social situations",
                        "requirement": {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Psychiatric illness ... would limit compliance with study requirements",
                        "criterion": "psychiatric illness",
                        "requirement": {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    },
                    {
                        "exact_snippets": "social situations ... would limit compliance with study requirements",
                        "criterion": "social situations",
                        "requirement": {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Known allergy to any of the study components",
                "criterions": [
                    {
                        "exact_snippets": "Known allergy to any of the study components",
                        "criterion": "allergy to study components",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Known allergy to any of the study components",
                        "criterion": "allergy to study components",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Advanced myelodysplastic syndrome (MDS; BM blasts >5%) or acute myeloid leukemia",
                "criterions": [
                    {
                        "exact_snippets": "Advanced myelodysplastic syndrome (MDS; BM blasts >5%)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "disease stage",
                            "expected_value": "advanced"
                        }
                    },
                    {
                        "exact_snippets": "Advanced myelodysplastic syndrome (MDS; BM blasts >5%)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "bone marrow blasts percentage",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "acute myeloid leukemia",
                        "criterion": "acute myeloid leukemia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Advanced myelodysplastic syndrome (MDS; BM blasts >5%)",
                                "criterion": "myelodysplastic syndrome (MDS)",
                                "requirement": {
                                    "requirement_type": "disease stage",
                                    "expected_value": "advanced"
                                }
                            },
                            {
                                "exact_snippets": "Advanced myelodysplastic syndrome (MDS; BM blasts >5%)",
                                "criterion": "myelodysplastic syndrome (MDS)",
                                "requirement": {
                                    "requirement_type": "bone marrow blasts percentage",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 5,
                                        "unit": "%"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "acute myeloid leukemia",
                        "criterion": "acute myeloid leukemia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Uncontrolled infection",
                "criterions": [
                    {
                        "exact_snippets": "Uncontrolled infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Uncontrolled infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prior radiation therapy deemed excessive by radiation therapist for proposed low dose TBI exposure on this protocol",
                "criterions": [
                    {
                        "exact_snippets": "Prior radiation therapy deemed excessive by radiation therapist for proposed low dose TBI exposure on this protocol",
                        "criterion": "prior radiation therapy",
                        "requirement": {
                            "requirement_type": "amount",
                            "expected_value": "excessive for proposed low dose TBI exposure as determined by radiation therapist"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prior radiation therapy deemed excessive by radiation therapist for proposed low dose TBI exposure on this protocol",
                        "criterion": "prior radiation therapy",
                        "requirement": {
                            "requirement_type": "amount",
                            "expected_value": "excessive for proposed low dose TBI exposure as determined by radiation therapist"
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* Pregnant, breastfeeding or intending to become pregnant during the study. Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment",
                "criterions": [
                    {
                        "exact_snippets": "Pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "breastfeeding",
                        "criterion": "breastfeeding status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "intending to become pregnant during the study",
                        "criterion": "intention to become pregnant during the study",
                        "requirement": {
                            "requirement_type": "intention",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment",
                        "criterion": "pregnancy test result within 7 days of the start of treatment",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    },
                    {
                        "exact_snippets": "Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment",
                        "criterion": "pregnancy test result within 7 days of the start of treatment",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "within 7 days of the start of treatment"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "breastfeeding",
                        "criterion": "breastfeeding status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "intending to become pregnant during the study",
                        "criterion": "intention to become pregnant during the study",
                        "requirement": {
                            "requirement_type": "intention",
                            "expected_value": true
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment",
                                "criterion": "pregnancy test result within 7 days of the start of treatment",
                                "requirement": {
                                    "requirement_type": "result",
                                    "expected_value": "positive"
                                }
                            },
                            {
                                "exact_snippets": "Persons of childbearing potential must have a negative pregnancy test (serum or urine) within 7 days of the start of treatment",
                                "criterion": "pregnancy test result within 7 days of the start of treatment",
                                "requirement": {
                                    "requirement_type": "timing",
                                    "expected_value": "within 7 days of the start of treatment"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Evidence of moderate or severe portal fibrosis or cirrhosis on biopsy",
                "criterions": [
                    {
                        "exact_snippets": "Evidence of moderate or severe portal fibrosis ... on biopsy",
                        "criterion": "portal fibrosis",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Evidence of moderate or severe portal fibrosis ... on biopsy",
                        "criterion": "portal fibrosis",
                        "requirement": {
                            "requirement_type": "evidence_on_biopsy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Evidence of ... cirrhosis on biopsy",
                        "criterion": "cirrhosis",
                        "requirement": {
                            "requirement_type": "evidence_on_biopsy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Diagnosis of an inherited bone marrow failure disorder such as Fanconi anemia, Telomere biology disorder, or Schwachman-Diamond syndrome, unless reviewed by the principal investigator and deemed appropriate for this approach (e.g. GATA2 deficiency)",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of an inherited bone marrow failure disorder such as Fanconi anemia, Telomere biology disorder, or Schwachman-Diamond syndrome",
                        "criterion": "inherited bone marrow failure disorder",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of an inherited bone marrow failure disorder such as Fanconi anemia, Telomere biology disorder, or Schwachman-Diamond syndrome",
                        "criterion": "inherited bone marrow failure disorder",
                        "requirement": {
                            "requirement_type": "subtype",
                            "expected_value": [
                                "Fanconi anemia",
                                "Telomere biology disorder",
                                "Schwachman-Diamond syndrome"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "unless reviewed by the principal investigator and deemed appropriate for this approach (e.g. GATA2 deficiency)",
                        "criterion": "principal investigator review and approval",
                        "requirement": {
                            "requirement_type": "reviewed and deemed appropriate",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}